{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:26Z","timestamp":1759333526866},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.mehy.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T05:49:51Z","timestamp":1236318591000},"page":"688-691","source":"Crossref","is-referenced-by-count":8,"title":["Insufficient evidence to deny antibiotic treatment to chronic Lyme disease patients"],"prefix":"10.1016","volume":"72","author":[{"given":"Daniel J.","family":"Cameron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.01.017_bib1","unstructured":"Lyme disease \u2013 United States. MMWR Morb Mortal Wkly Rep 2002;51(2):29\u201331."},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3201\/eid0604.000416","article-title":"Lyme disease surveillance in England and Wales, 1986\u20131998","volume":"6","author":"Smith","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.mehy.2009.01.017_bib3","first-page":"1","article-title":"Surveillance for Lyme disease \u2013 United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.mehy.2009.01.017_bib4","unstructured":"Lyme disease \u2013 United States, 2001\u20132002. MMWR Morb Mortal Wkly Rep 2004;53(17):365\u20139."},{"key":"10.1016\/j.mehy.2009.01.017_bib5","unstructured":"<http:\/\/www.ct.gov\/ag\/lib\/ag\/health\/0129lyme.pdf>; p. 290 [accessed 12.4.08]."},{"issue":"3","key":"10.1016\/j.mehy.2009.01.017_bib6","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.mehy.2009.01.017_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Int Med"},{"issue":"13","key":"10.1016\/j.mehy.2009.01.017_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/153036602321653842","article-title":"Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease","volume":"2","author":"Klempner","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"12","key":"10.1016\/j.mehy.2009.01.017_bib10","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mehy.2009.01.017_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2009.01.017_bib12","doi-asserted-by":"crossref","unstructured":"Cameron DJ. Clinical trials validate the severity of persistent Lyme disease symptoms. Med Hypotheses 2008.","DOI":"10.1016\/j.mehy.2008.09.030"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3201\/eid1204.050602","article-title":"Economic impact of Lyme disease","volume":"12","author":"Zhang","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2009.01.017_bib14","first-page":"S1","article-title":"Evidence-based guidelines for the management of Lyme disease","volume":"2","author":"Cameron","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.017_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.mehy.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis","volume":"312","author":"Steere","year":"1985","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.mehy.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mehy.2009.01.017_bib18","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med Sci Monit"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2009.01.017_bib19","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mehy.2009.01.017_bib20","first-page":"489","article-title":"Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial","volume":"99","author":"Cameron","year":"2008","journal-title":"Minerva Med"},{"issue":"14","key":"10.1016\/j.mehy.2009.01.017_bib21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14787210.2.4.533","article-title":"Treatment of Lyme disease: a medicolegal assessment","volume":"2","author":"Johnson","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib23","first-page":"429","article-title":"An appraisal of \u201cchronic Lyme disease\u201d","volume":"358","author":"Cameron","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mehy.2009.01.017_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/319366","article-title":"Guide to development of practice guidelines","volume":"32","author":"Kish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mehy.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2009.01.017_bib26","unstructured":"UnitedHealthCare. Treatment of chronic and recurrent Lyme disease. <http:\/\/www.unitedhealthcareonline.com\/b2c\/cmaIndexResult.do?channelId=016228193392b010VgnVCM100000c520720a____&htmlFilePath=\/ccmcontent\/ProviderII\/UHC\/en-US\/Assets\/ProviderStaticFiles\/ProviderStaticFilesHtml\/MedicalPolicies\/Treatment_of_Chronic_and_Recurrent_Lyme_Disease.htm>; [accessed 12.23.08]."},{"key":"10.1016\/j.mehy.2009.01.017_bib27","unstructured":"Cigna. Medical coverage policy Lyme disease treatment. <http:\/\/www.cigna.com\/customer_care\/healthcare_professional\/coverage_positions\/medical\/mm_0400_coveragepositioncriteria_lyme_disease_treatment.pdf>; [accessed 12.23.08]."},{"key":"10.1016\/j.mehy.2009.01.017_bib28","unstructured":"Aetna: Clinical Policy Bulletin. Lyme disease and other tick-borne diseases. <http:\/\/www.aetna.com\/cpb\/medical\/data\/200_299\/0215.html>; [accessed 12.23.08]."},{"key":"10.1016\/j.mehy.2009.01.017_bib29","unstructured":"BlueCross BlueShield of Wisconsin parenteral antibiotics for the treatment of Lyme disease. <http:\/\/www2.bluecrosswisconsin.com\/provider\/medpolicy\/policies\/MED\/lyme.html>; [accessed 12.23.08]."},{"key":"10.1016\/j.mehy.2009.01.017_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-5573-3-12","article-title":"Generalizability in two clinical trials of Lyme disease","volume":"3","author":"Cameron","year":"2006","journal-title":"Epidemiol Perspect Innov"},{"issue":"11\u201312","key":"10.1016\/j.mehy.2009.01.017_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"21","key":"10.1016\/j.mehy.2009.01.017_bib32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.017_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0163-4453(94)91105-3","article-title":"Treatment of late Lyme borreliosis","volume":"29","author":"Wahlberg","year":"1994","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.mehy.2009.01.017_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/314860","article-title":"Successful treatment of Lyme encephalopathy with intravenous ceftriaxone","volume":"180","author":"Logigian","year":"1999","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.mehy.2009.01.017_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.017_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/49.1.25","article-title":"The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance","volume":"49","author":"Levy","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.017_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2753.2006.00734.x","article-title":"Consequences of treatment delay in Lyme disease","volume":"13","author":"Cameron","year":"2007","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.017_bib38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00011-06","article-title":"Coinfections acquired from ixodes ticks","volume":"19","author":"Swanson","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"13","key":"10.1016\/j.mehy.2009.01.017_bib39","first-page":"1831","article-title":"Uncertainty about clinical equipoise","volume":"164","author":"Shrier","year":"2001","journal-title":"CMAJ"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T09:39:38Z","timestamp":1558172378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0306987709000632"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.01.017","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}